Comparison of the Nottingham Prognostic Index and OncotypeDX© recurrence score in predicting outcome in estrogen receptor positive breast cancer

INTRODUCTION: Traditionally, Nottingham prognostic index (NPI) informed prognosis in patients with estrogen receptor positive, human epidermal growth factor receptor-2 negative, node negative (ER+/HER2-/LN-) breast cancer. At present, OncotypeDX© Recurrence Score (RS) predicts prognosis and response...

Descripción completa

Detalles Bibliográficos
Autores principales: Kerin, Eoin P., Davey, Matthew G., McLaughlin, Ray P., Sweeney, Karl J., Barry, Michael K., Malone, Carmel M., Elwahab, Sami Abd, Lowery, Aoife J., Kerin, Michael J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9647009/
https://www.ncbi.nlm.nih.gov/pubmed/36335747
http://dx.doi.org/10.1016/j.breast.2022.11.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9647009/
https://www.ncbi.nlm.nih.gov/pubmed/36335747
http://dx.doi.org/10.1016/j.breast.2022.11.001

Ejemplares similares